ResearcherOklahoma City VA Medical CenterActive in the last 2 years

Landon L. Moore

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0594-7960; OpenAlex author ID A5037439079. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth. Co-author DOI 10.1038/s41598-025-19722-z ↗
Tuft Cells Play Critical Roles in the Heterogeneity and Epithelial Plasticity in Pancreatic Cancer Initiation and Progression. Co-author DOI 10.1053/j.gastro.2020.09.004 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Courtney W. Houchen · 2 shared papers, 2020–2025 · strength 0.43
- Paper A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth. DOI 10.1038/s41598-025-19722-z ↗
- Paper Tuft Cells Play Critical Roles in the Heterogeneity and Epithelial Plasticity in Pancreatic Cancer Initiation and Progr… DOI 10.1053/j.gastro.2020.09.004 ↗
Dongfeng Qu · 1 shared paper, 2025 · strength 0.27
- Paper A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth. DOI 10.1038/s41598-025-19722-z ↗
Zhijun Zhou · 1 shared paper, 2020 · strength 0.16
- Paper Tuft Cells Play Critical Roles in the Heterogeneity and Epithelial Plasticity in Pancreatic Cancer Initiation and Progr… DOI 10.1053/j.gastro.2020.09.004 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.